Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Top Wall Street Forecasters Revamp Humana Expectations Ahead Of Q3 Earnings

Author: Avi Kapoor | November 05, 2025 02:59am

Humana Inc. (NYSE:HUM) will release earnings results for the third quarter before the opening bell on Wednesday, Nov. 5.

Analysts expect the Louisville, Kentucky-based company to report quarterly earnings at $2.82 per share, down from $4.16 per share in the year-ago period. The consensus estimate for Humana's quarterly revenue is $32.01 billion, compared to $29.4 billion a year earlier, according to Benzinga Pro.

On Oct. 28, Humana announced that its board declared a cash dividend to stockholders of 88.5 cents per share.

Shares of Humana rose 0.7% to close at $281.87 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • B of A Securities analyst Kevin Fishbeck maintained a Neutral rating and raised the price target from $280 to $300 on Oct. 10, 2025. This analyst has an accuracy rate of 66%.
  • Mizuho analyst Ann Hynes maintained an Outperform rating and increased the price target from $300 to $345 on Oct. 9, 2025. This analyst has an accuracy rate of 72%.
  • Barclays analyst Andrew Mok maintained an Equal-Weight rating and cur the price target from $315 to $245 on Oct. 3, 2025. This analyst has an accuracy rate of 62%.
  • RBC Capital analyst Ben Hendrix maintained an Outperform rating and increased the price target from $283 to $322 on Aug. 21, 2025. This analyst has an accuracy rate of 62%.
  • Argus Research analyst David Toung reiterated a Hold rating with a price target of $281.99 on Aug. 14, 2025. This analyst has an accuracy rate of 67%

Considering buying HUM stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: HUM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist